Chargement en cours...
Linagliptin Attenuates Diabetes-Induced Cerebral Pathological Neovascularization in a Blood Glucose-Independent Manner: Potential Role of ET-1
AIMS: We have shown that glycemic control with metformin or endothelin-1 (ET-1) inhibition with bosentan prevents and restores diabetes-mediated cerebral pathological remodeling and neovascularization. Our recent data suggest that linagliptin, a member of the dipeptidyl peptidase-4 inhibitor class o...
Enregistré dans:
| Publié dans: | Life Sci |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4882278/ https://ncbi.nlm.nih.gov/pubmed/26631506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2015.11.026 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|